Lupus    B-VolcanicEruption107436475
miliaris    I-VolcanicEruption107436475
disseminatus    I-VolcanicEruption107436475
faciei    I-VolcanicEruption107436475

Scleroderma-like    B-VolcanicEruption107436475
reaction    I-VolcanicEruption107436475
to    I-VolcanicEruption107436475
taxanes    I-VolcanicEruption107436475
may    O
occur    O
in    O
patients    O
treated    O
with    O
docetaxel    O
or    O
paclitaxel    O
,    O
characterized    O
by    O
an    O
acute    O
,    O
diffuse    O
,    O
infiltrated    O
edema    O
of    O
the    O
extremities    O
and    O
head    O
.    O

Gnathophyma    B-VolcanicEruption107436475

Acrodermatitis    B-VolcanicEruption107436475
/ac·ro·der·ma·ti·tis/    O
is    O
a    O
childhood    O
form    O
of    O
dermatitis    O
selectively    O
affecting    O
the    O
hands    O
and    O
feet    O
and    O
may    O
be    O
accompanied    O
by    O
mild    O
symptoms    O
of    O
fever    O
and    O
malaise    O
.    O

The    O
2011    B-VolcanicEruption107436475
Nabro    I-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
was    O
an    O
eruption    O
of    O
the    O
Nabro    O
stratovolcano    O
in    O
the    O
Southern    O
Red    O
Sea    O
Region    O
of    O
Eritrea    O
,    O
which    O
began    O
on    O
12    O
June    O
2011    O
after    O
a    O
series    O
of    O
earthquakes    O
.    O

Otophyma    B-VolcanicEruption107436475

The    O
first    O
volcanic    O
winter    O
in    O
1816    O
,    O
known    O
as    O
the    O
Year    B-VolcanicEruption107436475
Without    I-VolcanicEruption107436475
a    I-VolcanicEruption107436475
Summer    I-VolcanicEruption107436475
,    O
affected    O
the    O
Canadian    O
province    O
of    O
Newfoundland    O
and    O
Labrador    O
.    O

Lord    O
Byron    O
,    O
Mary    O
Wollstonecraft    O
Godwin    O
,    O
Percy    O
Bysshe    O
Shelley    O
and    O
John    O
Polidori    O
,    O
gathered    O
at    O
the    O
Villa    O
Diodati    O
by    O
Lake    O
Geneva    O
in    O
a    O
rainy    O
Switzerland    O
in    O
this    O
'    O
Year    B-VolcanicEruption107436475
Without    I-VolcanicEruption107436475
a    I-VolcanicEruption107436475
Summer    I-VolcanicEruption107436475
'    O
,    O
tell    O
each    O
other    O
tales    O
.    O

The    O
eruption    O
sends    O
so    O
much    O
volcanic    O
ash    O
into    O
the    O
atmosphere    O
that    O
weather    O
patterns    O
around    O
the    O
world    O
are    O
altered    O
,    O
causing    O
1816    O
to    O
be    O
the    O
"    O
Year    B-VolcanicEruption107436475
Without    I-VolcanicEruption107436475
A    I-VolcanicEruption107436475
Summer    I-VolcanicEruption107436475
"    O
.    O

Written    O
in    O
1816    O
—    O
the    O
"    O
Year    B-VolcanicEruption107436475
Without    I-VolcanicEruption107436475
a    I-VolcanicEruption107436475
Summer    I-VolcanicEruption107436475
"    O
,    O
caused    O
by    O
atmospheric    O
ash    O
from    O
the    O
volcano    O
Mount    O
Tambora    O
erupting    O
in    O
the    O
Dutch    O
East    O
Indies    O
—    O
"    O
Darkness    O
"    O
depicts    O
a    O
world    O
grown    O
dark    O
and    O
cold    O
because    O
the    O
sun    O
has    O
been    O
extinguished    O
.    O

Its    O
brilliant    O
colours    O
may    O
have    O
been    O
influenced    O
by    O
atmospheric    O
ash    O
from    O
the    O
eruption    O
of    O
Mount    O
Tambora    O
in    O
Indonesia    O
(    O
see    O
also    O
Year    B-VolcanicEruption107436475
Without    I-VolcanicEruption107436475
a    I-VolcanicEruption107436475
Summer    I-VolcanicEruption107436475
)    O
.    O

This    O
year    O
is    O
known    O
as    O
the    O
"    O
Year    B-VolcanicEruption107436475
Without    I-VolcanicEruption107436475
a    I-VolcanicEruption107436475
Summer    I-VolcanicEruption107436475
"    O
after    O
Mount    O
Tambora    O
had    O
erupted    O
in    O
the    O
Dutch    O
East    O
Indies    O
the    O
previous    O
year    O
and    O
cast    O
enough    O
ash    O
into    O
the    O
atmosphere    O
to    O
block    O
out    O
the    O
sun    O
and    O
cause    O
abnormal    O
weather    O
across    O
much    O
of    O
Northern    O
Europe    O
and    O
the    O
Northeastern    O
United    O
States    O
.    O

In    O
1816    O
,    O
the    O
Year    B-VolcanicEruption107436475
Without    I-VolcanicEruption107436475
a    I-VolcanicEruption107436475
Summer    I-VolcanicEruption107436475
,    O
bad    O
grain    O
harvests    O
along    O
with    O
their    O
attendant    O
unpleasant    O
consequences    O
led    O
ten    O
local    O
day    O
-    O
labourer    O
families    O
with    O
all    O
together    O
51    O
persons    O
to    O
emigrate    O
.    O

In    O
parts    O
of    O
Europe    O
,    O
Asia    O
and    O
North    O
America    O
,    O
1816    O
was    O
known    O
as    O
the    O
"    O
Year    B-VolcanicEruption107436475
Without    I-VolcanicEruption107436475
a    I-VolcanicEruption107436475
Summer    I-VolcanicEruption107436475
"    O
,    O
which    O
caused    O
a    O
considerable    O
agricultural    O
distress    O
and    O
a    O
brief    O
but    O
bitter    O
famine    O
.    O

After    O
an    O
increase    O
of    O
the    O
glacier    O
during    O
the    O
"    O
Year    B-VolcanicEruption107436475
Without    I-VolcanicEruption107436475
a    I-VolcanicEruption107436475
Summer    I-VolcanicEruption107436475
"    O
,    O
an    O
ice    O
cone    O
started    O
to    O
form    O
in    O
1816    O
in    O
the    O
valley    O
.    O

Hans    O
-    O
Erhard    O
Lessing    O
(    O
Drais    O
'    O
biographer    O
)    O
found    O
from    O
circumstantial    O
evidence    O
that    O
Drais    O
'    O
interest    O
in    O
finding    O
an    O
alternative    O
to    O
the    O
horse    O
was    O
the    O
starvation    O
and    O
death    O
of    O
horses    O
caused    O
by    O
crop    O
failure    O
in    O
1816    O
,    O
the    O
Year    B-VolcanicEruption107436475
Without    I-VolcanicEruption107436475
a    I-VolcanicEruption107436475
Summer    I-VolcanicEruption107436475
following    O
the    O
volcanic    O
eruption    O
of    O
Tambora    O
in    O
1815    O
)    O
.    O

"    O
For    O
the    O
year    O
(    O
1816    O
)    O
in    O
which    O
severe    O
summer    O
climate    O
abnormalities    O
caused    O
average    O
global    O
temperatures    O
to    O
decrease    O
drastically    O
see    O
Year    B-VolcanicEruption107436475
Without    I-VolcanicEruption107436475
a    I-VolcanicEruption107436475
Summer    I-VolcanicEruption107436475
(    O
also    O
known    O
as    O
The    O
Summer    O
That    O
Never    O
Was    O
)    O
"    O

Only    O
for    O
a    O
short    O
time    O
after    O
the    O
end    O
of    O
the    O
Coalition    O
Wars    O
a    O
worldwide    O
climate    O
disaster    O
happened    O
following    O
the    O
eruption    O
of    O
a    O
volcano    O
in    O
Indonesia    O
in    O
1816    O
,    O
the    O
so    O
called    O
Year    B-VolcanicEruption107436475
Without    I-VolcanicEruption107436475
a    I-VolcanicEruption107436475
Summer    I-VolcanicEruption107436475
.    O

half    O
-    O
timber    O
church    O
and    O
hunger    B-VolcanicEruption107436475
lime    O
tree    O
in    O
Langenbeutingen    O
.    O

Year    B-VolcanicEruption107436475
Without    I-VolcanicEruption107436475
a    I-VolcanicEruption107436475
Summer    I-VolcanicEruption107436475
summer    O
had    O
severe    O
climate    O
abnormalities    O
resulting    O
in    O
major    O
food    O
shortages    O
across    O
the    O
Northern    O
Hemisphere    O

Periorificial    B-VolcanicEruption107436475
dermatitis    I-VolcanicEruption107436475

Drug-induced    B-VolcanicEruption107436475
systemic    I-VolcanicEruption107436475
lupus    I-VolcanicEruption107436475
erythematosus    I-VolcanicEruption107436475

Drug-induced    B-VolcanicEruption107436475
lupus    I-VolcanicEruption107436475
erythematosus    I-VolcanicEruption107436475
(    O
DIL    O
or    O
DILE    O
)    O
is    O
an    O
autoimmune    O
disorder    O
(    O
similar    O
to    O
systemic    O
lupus    O
erythematosus    O
[    O
SLE    O
]    O
)    O
caused    O
by    O
chronic    O
use    O
of    O
certain    O
drugs    O
.    O

Kwee    O
was    O
inspired    O
by    O
the    O
1883    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Krakatoa    I-VolcanicEruption107436475
.    O

1883    O
–    O
Krakatoa    O
begins    B-VolcanicEruption107436475
to    I-VolcanicEruption107436475
erupt    I-VolcanicEruption107436475
;    O
the    O
volcano    O
explodes    O
three    O
months    O
later    O
,    O
killing    O
more    O
than    O
36,000    O
people    O
.    O

However    O
,    O
Krakatoa    O
becomes    O
more    O
active    O
,    O
and    O
soon    O
enough    O
,    O
the    O
volcano    B-VolcanicEruption107436475
violently    I-VolcanicEruption107436475
explodes    I-VolcanicEruption107436475
.    O

His    O
laboratory    O
was    O
also    O
destroyed    O
during    O
the    O
eruption    B-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Krakatoa    I-VolcanicEruption107436475
.    O

This    O
would    O
also    O
be    O
equivalent    O
to    O
16    O
times    O
the    O
1883    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Krakatoa    I-VolcanicEruption107436475
which    O
was    O
200    O
Mt    O
and    O
had    O
a    O
Volcanic    O
Explosivity    O
Index    O
of    O
6    O
.    O

Two    O
famous    O
stratovolcanoes    O
are    O
Krakatoa    O
,    O
best    O
known    O
for    O
its    O
catastrophic    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
in    I-VolcanicEruption107436475
1883    I-VolcanicEruption107436475
and    O
Vesuvius    O
,    O
famous    O
for    O
its    O
destruction    B-VolcanicEruption107436475
of    I-VolcanicEruption107436475
the    I-VolcanicEruption107436475
towns    I-VolcanicEruption107436475
Pompeii    I-VolcanicEruption107436475
and    I-VolcanicEruption107436475
Herculaneum    I-VolcanicEruption107436475
in    I-VolcanicEruption107436475
79    I-VolcanicEruption107436475
CE    I-VolcanicEruption107436475
.    O

The    O
town    O
was    O
a    O
considerable    O
port    O
in    O
the    O
19th    O
century    O
,    O
but    O
was    O
completely    O
destroyed    O
by    O
the    O
1883    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    O
Krakatoa    O
.    O

Tsunami    O
deposits    O
of    O
the    O
same    O
age    O
have    O
been    O
found    O
on    O
the    O
central    O
New    O
Zealand    O
coast    O
,    O
evidence    O
that    O
the    O
eruption    O
caused    O
local    O
tsunamis    O
,    O
but    O
much    O
more    O
widespread    O
waves    O
may    O
have    O
been    O
generated    O
(    O
like    O
those    O
observed    O
after    O
the    O
1883    B-VolcanicEruption107436475
Krakatoa    I-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
)    O
.    O

Periorbital    B-VolcanicEruption107436475
dermatitis    I-VolcanicEruption107436475
(    O
periocular    O
dermatitis    O
)    O

When    O
it    O
occurs    O
with    O
acne    B-VolcanicEruption107436475
conglobata    I-VolcanicEruption107436475
,    O
hidradenitis    B-VolcanicEruption107436475
suppurativa    I-VolcanicEruption107436475
,    O
and    O
pilonidal    O
cysts    O
,    O
the    O
syndrome    O
is    O
referred    O
to    O
as    O
the    O
follicular    O
occlusion    O
triad    O
or    O
tetrad    O
.    O

Acne    B-VolcanicEruption107436475
conglobata    I-VolcanicEruption107436475

Idiopathic    B-VolcanicEruption107436475
facial    I-VolcanicEruption107436475
aseptic    I-VolcanicEruption107436475
granuloma    I-VolcanicEruption107436475

Pustulosis    B-VolcanicEruption107436475
palmaris    I-VolcanicEruption107436475
et    I-VolcanicEruption107436475
plantaris    I-VolcanicEruption107436475
is    O
another    O
form    O
of    O
localized    O
pustular    O
psoriasis    O
similar    O
to    O
acrodermatitis    O
continua    O
with    O
pustules    O
erupting    O
from    O
red    O
,    O
tender    O
,    O
scaly    O
skin    O
found    O
on    O
the    O
palms    O
of    O
the    O
hands    O
and    O
the    O
soles    O
of    O
the    O
feet    O
.    O

Gram-negative    B-VolcanicEruption107436475
rosacea    I-VolcanicEruption107436475

Acne    B-VolcanicEruption107436475
fulminans    I-VolcanicEruption107436475
(    O
acute    O
febrile    O
ulcerative    O
acne    O
)    O

Chemotherapy-induced    B-VolcanicEruption107436475
hyperpigmentation    I-VolcanicEruption107436475
is    O
caused    O
by    O
many    O
chemotherapeutic    O
agents    O
(    O
especially    O
the    O
antibiotics    O
bleomycin    O
,    O
and    O
daunorubicin    O
)    O
and    O
the    O
alkylating    O
agents    O
(    O
cyclophosphamide    O
and    O
busulfan    O
)    O
.    O

Chronic    B-VolcanicEruption107436475
bullous    I-VolcanicEruption107436475
disease    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
childhood    I-VolcanicEruption107436475

Linear    B-VolcanicEruption107436475
immunoglobulin-A    I-VolcanicEruption107436475
disease    I-VolcanicEruption107436475
(    O
linear    O
IgA    O
disease    O
)    O

Drug    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475

Rare    O
side    O
effects    O
include    O
flushing    O
of    O
the    O
face    O
,    O
hyperhidrosis    O
(    O
excessive    O
sweating    O
)    O
,    O
cutaneous    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
,    O
arterial    O
hypotension    O
,    O
tachycardia    O
,    O
loss    O
of    O
appetite    O
,    O
jaundice    O
,    O
eosinophilia    O
,    O
thrombopenia    O
,    O
mixed    O
hepatitis    O
,    O
headache    O
,    O
allergic    O
reaction    O
,    O
chronic    O
active    O
hepatitis    O
,    O
and    O
paradoxical    O
aggravation    O
of    O
cerebral    O
vasospasm    O
.    O

Drug-induced    B-VolcanicEruption107436475
pigmentation    I-VolcanicEruption107436475

Allopurinol    B-VolcanicEruption107436475
hypersensitivity    I-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475

Drug-induced    B-VolcanicEruption107436475
urticaria    I-VolcanicEruption107436475

Hundreds    O
of    O
flights    O
were    O
cancelled    O
as    O
a    O
result    O
of    O
the    O
eruption    B-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Grímsvötn    I-VolcanicEruption107436475
volcano    I-VolcanicEruption107436475
.    O

Rosacea    B-VolcanicEruption107436475

Other    O
rosacea    B-VolcanicEruption107436475

Rosacea    B-VolcanicEruption107436475
,    O
unspecified    O

Rosacea    B-VolcanicEruption107436475

Brian    O
is    O
known    O
for    O
having    O
several    O
ailments    O
including    O
asthma    O
,    O
hypoglycemia    O
,    O
a    O
deviated    O
septum    O
,    O
and    O
rosacea    B-VolcanicEruption107436475
.    O

Azelaic    O
acid    O
is    O
also    O
used    O
as    O
a    O
topical    O
gel    O
treatment    O
for    O
rosacea    B-VolcanicEruption107436475
,    O
due    O
to    O
its    O
ability    O
to    O
reduce    O
inflammation    O
.    O

Various    O
diseases    O
and    O
conditions    O
can    O
lead    O
to    O
blepharitis    O
,    O
such    O
as    O
rosacea    B-VolcanicEruption107436475
,    O
herpes    O
simplex    O
dermatitis    O
,    O
varicella    O
-    O
zoster    O
dermatitis    O
,    O
molluscum    O
contagiosum    O
,    O
allergic    O
dermatitis    O
,    O
contact    O
dermatitis    O
,    O
seborrheic    O
dermatitis    O
,    O
staphylococcal    O
dermatitis    O
,    O
and    O
parasitic    O
infections    O
(    O
"    O
e.g.    O
"    O
,    O
Demodex    O
and    O
Phthiriasis    O
palpebrarum    O
)    O
.    O

It    O
may    O
be    O
associated    O
with    O
skin    O
rosacea    B-VolcanicEruption107436475
,    O
and    O
there    O
is    O
growing    O
evidence    O
that    O
in    O
some    O
cases    O
it    O
is    O
caused    O
by    O
demodex    O
mites    O
.    O

Blepharitis    O
caused    O
by    O
seborrheic    O
dermatitis    O
,    O
rosacea    B-VolcanicEruption107436475
,    O
or    O
other    O
diseases    O
may    O
be    O
controlled    O
by    O
treating    O
the    O
underlying    O
disease    O
.    O

Their    O
hierarchy    O
is    O
reflected    O
by    O
how    O
mutated    O
they    O
were    O
:    O
newcomers    O
had    O
low    O
level    O
infections    O
which    O
resemble    O
rosacea    B-VolcanicEruption107436475
,    O
while    O
veterans    O
had    O
full    O
-    O
blown    O
undersea    O
creature    O
attributes    O
.    O

Demodex    O
mites    O
,    O
which    O
are    O
common    O
cause    O
of    O
mange    O
in    O
dogs    O
and    O
other    O
domesticated    O
animals    O
,    O
have    O
also    O
been    O
implicated    O
in    O
the    O
human    O
skin    O
disease    O
rosacea    B-VolcanicEruption107436475
,    O
although    O
the    O
mechanism    O
by    O
which    O
demodex    O
contributes    O
to    O
the    O
disease    O
is    O
unclear    O
.    O

Fiddler    O
’s    O
neck    O
can    O
be    O
differentiated    O
from    O
rosacea    B-VolcanicEruption107436475
and    O
sarcoid    O
reaction    O
with    O
granulomas    O
.    O

Clobetasol    O
propionate    O
is    O
used    O
for    O
the    O
treatment    O
of    O
various    O
skin    O
disorders    O
including    O
eczema    O
,    O
herpes    O
labialis    O
,    O
psoriasis    O
,    O
and    O
lichen    B-VolcanicEruption107436475
sclerosus    I-VolcanicEruption107436475
.    O

Lichen    B-VolcanicEruption107436475
sclerosus    I-VolcanicEruption107436475
overlap    O
syndrome    O
,    O
sharing    O
features    O
of    O
lichen    O
planus    O
and    O
lichen    O
sclerosus    O
.    O

Lichen    B-VolcanicEruption107436475
sclerosus    I-VolcanicEruption107436475
,    O
a    O
skin    O
disease    O

Lichen    B-VolcanicEruption107436475
sclerosus    I-VolcanicEruption107436475
et    I-VolcanicEruption107436475
atrophicus    I-VolcanicEruption107436475

Lichen    B-VolcanicEruption107436475
sclerosus    I-VolcanicEruption107436475

Urticarial    B-VolcanicEruption107436475
erythema    I-VolcanicEruption107436475
multiforme    I-VolcanicEruption107436475
is    O
an    O
unusual    O
reaction    O
virtually    O
always    O
associated    O
with    O
antibiotic    O
ingestions    O
,    O
characterized    O
by    O
skin    O
lesions    O
that    O
consist    O
of    O
urticarial    O
papules    O
and    O
plaques    O
,    O
some    O
of    O
which    O
clear    O
centrally    O
forming    O
annular    O
lesions    O
,    O
but    O
with    O
no    O
true    O
urticarial    O
lesions    O
.    O

There    O
is    O
evidence    O
,    O
most    O
notably    O
in    O
the    O
eastern    O
walls    O
of    O
the    O
tetrastyle    O
atrium    O
,    O
that    O
after    O
the    O
great    O
earthquake    O
in    O
AD    O
62    O
,    O
the    O
House    O
of    O
the    O
Faun    O
was    O
rebuilt    O
and/or    O
repaired    O
;    O
yet    O
,    O
the    O
building    O
was    O
only    O
used    O
again    O
until    O
AD    O
79    O
,    O
ultimately    O
rendered    O
unusable    O
by    O
the    O
eruption    B-VolcanicEruption107436475
of    O
Mount    O
Vesuvius    O
.    O

Parts    O
of    O
the    O
Macellum    O
were    O
damaged    O
in    O
the    O
earthquake    O
of    O
62    O
CE    O
,    O
and    O
these    O
damages    O
were    O
not    O
repaired    O
before    O
the    O
eruption    B-VolcanicEruption107436475
that    O
destroyed    O
Pompeii    O
in    O
the    O
year    O
79    O
AD    O
.    O

Two    O
famous    O
stratovolcanoes    O
are    O
Krakatoa    O
,    O
best    O
known    O
for    O
its    O
catastrophic    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
in    I-VolcanicEruption107436475
1883    I-VolcanicEruption107436475
and    O
Vesuvius    O
,    O
famous    O
for    O
its    O
destruction    B-VolcanicEruption107436475
of    I-VolcanicEruption107436475
the    I-VolcanicEruption107436475
towns    I-VolcanicEruption107436475
Pompeii    I-VolcanicEruption107436475
and    I-VolcanicEruption107436475
Herculaneum    I-VolcanicEruption107436475
in    I-VolcanicEruption107436475
79    I-VolcanicEruption107436475
CE    I-VolcanicEruption107436475
.    O

Mount    O
Vesuvius    O
near    O
Naples    O
,    O
Italy    O
,    O
erupted    B-VolcanicEruption107436475
in    I-VolcanicEruption107436475
79    I-VolcanicEruption107436475
AD    I-VolcanicEruption107436475
.    O

Any    O
subsequent    O
eruption    O
may    O
produce    O
distinctly    O
layered    O
deposits    O
;    O
for    O
example    O
,    O
the    O
deposits    O
from    O
the    O
79    B-VolcanicEruption107436475
AD    I-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
Vesuvius    I-VolcanicEruption107436475
include    O
a    O
thick    O
layer    O
of    O
white    O
pumice    O
from    O
the    O
upper    O
portion    O
of    O
the    O
magma    O
chamber    O
overlaid    O
with    O
a    O
similar    O
layer    O
of    O
grey    O
pumice    O
produced    O
from    O
material    O
erupted    O
later    O
from    O
lower    O
in    O
the    O
chamber    O
.    O

The    O
painting    O
is    O
a    O
monumental    O
canvas    O
by    O
which    O
depicts    O
a    O
view    O
from    O
Stabiae    O
across    O
the    O
Bay    O
of    O
Naples    O
towards    O
the    O
doomed    O
cities    O
of    O
Pompeii    O
and    O
Herculaneum    O
during    O
the    O
eruption    B-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Vesuvius    I-VolcanicEruption107436475
in    I-VolcanicEruption107436475
AD    I-VolcanicEruption107436475
79    I-VolcanicEruption107436475
.    O

79    O
AD    O
–    O
Mount    O
Vesuvius    O
erupts    B-VolcanicEruption107436475
.    O

In    O
2002    O
excavations    O
on    O
the    O
villa    O
started    O
again    O
which    O
determined    O
that    O
the    O
villa    O
was    O
buried    O
during    O
the    O
eruption    O
of    O
Vesuvius    O
of    O
472    O
AD    O
and    O
not    O
79    B-VolcanicEruption107436475
AD    I-VolcanicEruption107436475
(    O
like    O
that    O
which    O
buried    O
Pompeii    O
etc    O
.    O
)    O
,    O
and    O
so    O
was    O
part    O
of    O
the    O
community    O
that    O
continued    O
after    O
the    O
earlier    O
eruption    O
and    O
recovered    O
better    O
than    O
the    O
territories    O
to    O
the    O
south    O
.    O

It    O
was    O
found    O
in    O
the    O
ruins    O
of    O
Pompeii    O
,    O
at    O
Herculaneum    O
,    O
a    O
city    O
buried    O
in    O
the    O
ash    O
of    O
Mount    B-VolcanicEruption107436475
Vesuvius    I-VolcanicEruption107436475
.    O

The    O
winery    O
is    O
also    O
behind    O
the    O
"    O
Villa    O
dei    O
Misteri    O
"    O
project    O
at    O
Pompeii    O
that    O
is    O
recreating    O
the    O
wines    O
of    O
the    O
ancient    O
Roman    O
city    O
by    O
replanting    O
vineyards    O
that    O
were    O
destroyed    O
by    O
the    O
eruption    B-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
Vesuvius    I-VolcanicEruption107436475
in    I-VolcanicEruption107436475
AD    I-VolcanicEruption107436475
79    I-VolcanicEruption107436475
using    O
the    O
same    O
ancient    O
grape    O
varieties    O
,    O
viticulture    O
and    O
winemaking    O
techniques    O
of    O
that    O
period    O
.    O

Neonatal    B-VolcanicEruption107436475
acne    I-VolcanicEruption107436475
(    O
acne    O
infantum    O
,    O
acne    O
neonatorum    O
,    O
neonatal    O
cephalic    O
pustulosis    O
)    O

Giant    B-VolcanicEruption107436475
cell    I-VolcanicEruption107436475
lichenoid    I-VolcanicEruption107436475
dermatitis    I-VolcanicEruption107436475

Persistent    B-VolcanicEruption107436475
edema    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
rosacea    I-VolcanicEruption107436475
(    O
chronic    O
upper    O
facial    O
erythematous    O
edema    O
,    O
Morbihan    O
's    O
disease    O
,    O
rosaceous    O
lymphedema    O
)    O

Drug-induced    B-VolcanicEruption107436475
pseudolymphoma    I-VolcanicEruption107436475

Drug-induced    B-VolcanicEruption107436475
angioedema    I-VolcanicEruption107436475

Acne    B-VolcanicEruption107436475
keloidalis    I-VolcanicEruption107436475
nuchae    I-VolcanicEruption107436475
(    O
acne    O
keloidalis    O
,    O
dermatitis    O
papillaris    O
capillitii    O
,    O
folliculitis    O
keloidalis    O
,    O
folliculitis    O
keloidis    O
nuchae    O
,    O
nuchal    O
keloid    O
acne    O
)    O

Erythema    B-VolcanicEruption107436475
dyschromicum    I-VolcanicEruption107436475
perstans    I-VolcanicEruption107436475
(    O
ashy    O
dermatosis    O
,    O
dermatosis    O
cinecienta    O
)    O

Tar    B-VolcanicEruption107436475
acne    I-VolcanicEruption107436475

Heart    O
Peaks    O
is    O
one    O
of    O
the    O
four    O
volcanoes    O
in    O
the    O
Northern    O
Cordilleran    O
Volcanic    O
Province    O
suggested    O
to    O
have    O
erupted    O
the    O
Finlay    B-VolcanicEruption107436475
tephras    I-VolcanicEruption107436475
.    O

Fixed    B-VolcanicEruption107436475
drug    I-VolcanicEruption107436475
reactions    I-VolcanicEruption107436475
are    O
common    O
and    O
so    O
named    O
because    O
they    O
recur    O
at    O
the    O
same    O
site    O
with    O
each    O
exposure    O
to    O
a    O
particular    O
medication    O
.    O

Anonychia    O
is    O
the    O
absence    O
of    O
nails    O
,    O
an    O
anomaly    O
,    O
which    O
may    O
be    O
the    O
result    O
of    O
a    O
congenital    O
ectodermal    O
defect    O
,    O
ichthyosis    O
,    O
severe    O
infection    O
,    O
severe    O
allergic    O
contact    O
dermatitis    O
,    O
self    O
-    O
inflicted    O
trauma    O
,    O
Raynaud    O
phenomenon    O
,    O
lichen    B-VolcanicEruption107436475
planus    I-VolcanicEruption107436475
,    O
epidermolysis    O
bullosa    O
,    O
or    O
severe    O
exfoliative    O
diseases    O
.    O

Lichen    B-VolcanicEruption107436475
planus    I-VolcanicEruption107436475

Lichenoid    B-VolcanicEruption107436475
trikeratosis    I-VolcanicEruption107436475
is    O
a    O
cutaneous    O
condition    O
that    O
may    O
be    O
related    O
to    O
keratosis    B-VolcanicEruption107436475
lichenoides    I-VolcanicEruption107436475
chronica    I-VolcanicEruption107436475
.    O

Lichen    B-VolcanicEruption107436475
verrucosus    I-VolcanicEruption107436475
et    I-VolcanicEruption107436475
reticularis    I-VolcanicEruption107436475
is    O
a    O
cutaneous    O
condition    O
that    O
may    O
be    O
related    O
to    O
keratosis    B-VolcanicEruption107436475
lichenoides    I-VolcanicEruption107436475
chronica    I-VolcanicEruption107436475
.    O

Verrucous    O
lupus    O
erythematosus    O
(    O
also    O
known    O
as    O
"    O
Hypertrophic    O
lupus    O
erythematosus    O
"    O
)    O
presents    O
with    O
non    O
-    O
pruritic    O
papulonodular    O
lesions    O
on    O
the    O
arms    O
and    O
hands    O
,    O
resembling    O
keratoacanthoma    O
or    O
hypertropic    O
lichen    B-VolcanicEruption107436475
planus    I-VolcanicEruption107436475
.    O

Grinspan    O
syndrome    O
is    O
a    O
syndrome    O
characterized    O
by    O
presence    O
of    O
the    O
triad    O
:    O
essential    O
hypertension    O
,    O
diabetes    O
mellitus    O
,    O
and    O
oral    O
lichen    B-VolcanicEruption107436475
planus    I-VolcanicEruption107436475
.    O

"    O
Koebnerization    O
"    O
may    O
also    O
occur    O
with    O
skin    O
disorders    O
such    O
as    O
vitiligo    O
and    O
lichen    B-VolcanicEruption107436475
planus    I-VolcanicEruption107436475
.    O

Lichenoid    B-VolcanicEruption107436475
reaction    I-VolcanicEruption107436475
such    O
as    O
skin    O
lesions    O
or    O
rashes    O

Psoriasis    O
in    O
the    O
mouth    O
is    O
very    O
rare    O
,    O
in    O
contrast    O
to    O
lichen    B-VolcanicEruption107436475
planus    I-VolcanicEruption107436475
,    O
another    O
common    O
papulosquamous    O
disorder    O
that    O
commonly    O
involves    O
both    O
the    O
skin    O
and    O
mouth    O
.    O

The    O
differential    O
diagnoses    O
of    O
fiddler    O
’s    O
neck    O
include    O
branchial    O
cleft    O
cyst    O
,    O
disease    O
of    O
the    O
salivary    O
glands    O
,    O
tumors    O
of    O
the    O
parotid    O
gland    O
,    O
psoriasis    O
,    O
lichen    B-VolcanicEruption107436475
planus    I-VolcanicEruption107436475
,    O
contact    O
dermatitis    O
,    O
herpes    O
simplex    O
and    O
similar    O
infections    O
,    O
and    O
insect    O
bites    O
and    O
stings    O
especially    O
from    O
fleas    O
.    O

It    O
has    O
been    O
reported    O
that    O
some    O
cases    O
of    O
lichen    B-VolcanicEruption107436475
planus    I-VolcanicEruption107436475
have    O
been    O
successfully    O
treated    O
with    O
basiliximab    O
as    O
an    O
alternative    O
therapy    O
to    O
ciclosporin    O
.    O

Centrocyte    O
can    O
also    O
refer    O
to    O
a    O
cell    O
with    O
a    O
protoplasm    O
that    O
contains    O
single    O
and    O
double    O
granules    O
of    O
varying    O
size    O
stainable    O
with    O
hematoxylin    O
,    O
as    O
seen    O
in    O
lesions    O
of    O
lichen    B-VolcanicEruption107436475
planus    I-VolcanicEruption107436475
,    O
or    O
a    O
nondividing    O
,    O
activated    O
B    O
cell    O
that    O
expresses    O
membrane    O
immunoglobulin    O
.    O

Oral    O
ulceration    O
(    O
e.g.    O
aphthous    O
stomatitis    O
,    O
erosive    O
oral    O
lichen    B-VolcanicEruption107436475
planus    I-VolcanicEruption107436475
,    O
etc    O
.    O
)    O

Lichen    B-VolcanicEruption107436475
planus    I-VolcanicEruption107436475

There    O
are    O
many    O
skin    O
diseases    O
which    O
develop    O
papules    O
,    O
such    O
as    O
Lichen    B-VolcanicEruption107436475
planus    I-VolcanicEruption107436475
,    O
a    O
skin    O
disease    O
which    O
classically    O
forms    O
polygonal    O
,    O
purple    O
papules    O
.    O

Blepharophyma    B-VolcanicEruption107436475

Vitamin    B-VolcanicEruption107436475
K    I-VolcanicEruption107436475
reaction    I-VolcanicEruption107436475

Acute    B-VolcanicEruption107436475
generalized    I-VolcanicEruption107436475
exanthematous    I-VolcanicEruption107436475
pustulosis    I-VolcanicEruption107436475

Acute    B-VolcanicEruption107436475
generalized    I-VolcanicEruption107436475
exanthematous    I-VolcanicEruption107436475
pustulosis    I-VolcanicEruption107436475

Interstitial    B-VolcanicEruption107436475
granulomatous    I-VolcanicEruption107436475
drug    I-VolcanicEruption107436475
reaction    I-VolcanicEruption107436475

Drug-induced    B-VolcanicEruption107436475
keratoderma    I-VolcanicEruption107436475

The    O
most    O
common    O
side    O
effects    O
reported    O
in    O
patients    O
treated    O
with    O
regorafenib    O
include    O
weakness    O
or    O
fatigue    O
,    O
loss    O
of    O
appetite    O
,    O
hand-foot    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
(    O
also    O
called    O
palmar    O
-    O
plantar    O
erythrodysesthesia    O
)    O
,    O
diarrhoea    O
,    O
mouth    O
sores    O
(    O
mucousitis    O
)    O
,    O
weight    O
loss    O
,    O
infection    O
,    O
high    O
blood    O
pressure    O
,    O
and    O
changes    O
in    O
voice    O
volume    O
or    O
quality    O
(    O
dysphonia    O
)    O
.    O

Toxicity    O
:    O
leukopenia    O
,    O
thrombocytopenia    O
,    O
anemia    O
,    O
GI    O
disturbances    O
,    O
stomatitis    O
,    O
conjunctivitis    O
,    O
pneumonitis    O
,    O
fever    O
,    O
and    O
dermatitis    O
,    O
palmar-plantar    B-VolcanicEruption107436475
erythrodysesthesia    I-VolcanicEruption107436475
.    O

Some    O
people    O
develop    O
soreness    O
,    O
redness    O
and    O
peeling    O
on    O
the    O
palms    O
of    O
the    O
hands    O
and    O
soles    O
of    O
the    O
feet    O
(    O
plantar    B-VolcanicEruption107436475
palmar    I-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
)    O
.    O

Texier's    B-VolcanicEruption107436475
disease    I-VolcanicEruption107436475

"    O
Lichen    B-VolcanicEruption107436475
nitidus    I-VolcanicEruption107436475
"    O
,    O
a    O
chronic    O
inflammatory    O
disease    O
of    O
unknown    O
etiology    O

Lichen    B-VolcanicEruption107436475
nitidus    I-VolcanicEruption107436475

Livedoid    B-VolcanicEruption107436475
dermatitis    I-VolcanicEruption107436475

The    O
ignimbrite    B-VolcanicEruption107436475
flare-up    I-VolcanicEruption107436475
formed    O
a    O
series    O
of    O
ignimbrite    O
formations    O
,    O
layered    O
one    O
atop    O
another    O
,    O
that    O
are    O
sometimes    O
broken    O
by    O
lava    O
flows    O
.    O

Lichen    B-VolcanicEruption107436475
ruber    I-VolcanicEruption107436475
moniliformis    I-VolcanicEruption107436475

The    O
need    O
for    O
a    O
larger    O
terminal    O
and    O
ramp    O
was    O
obvious    O
after    O
the    O
2010    B-VolcanicEruption107436475
eruptions    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Eyjafjallajökull    I-VolcanicEruption107436475
,    O
when    O
many    O
international    O
flights    O
were    O
operated    O
from    O
Akureyri    O
when    O
Keflavík    O
airport    O
was    O
closed    O
due    O
to    O
volcanic    O
ash    O
.    O

From    O
the    O
15th    O
to    O
20    O
April    O
2010    O
,    O
under    O
internationally    O
agreed    O
guidelines    O
that    O
require    O
a    O
zero    O
tolerance    O
approach    O
to    O
ash    O
,    O
NATS    O
placed    O
a    O
series    O
of    O
restrictions    O
on    O
aircraft    O
operating    O
in    O
UK    O
controlled    O
airspace    O
owing    O
to    O
the    O
potential    O
dangers    O
caused    O
by    O
a    O
volcanic    O
ash    O
cloud    O
from    O
the    O
eruption    O
of    O
Icelandic    O
volcano    O
Eyjafjallajökull    B-VolcanicEruption107436475
,    O
in    O
co    O
-    O
operation    O
with    O
the    O
Met    O
Office    O
,    O
CAA    O
and    O
UK    O
Government    O
.    O

The    O
band    O
had    O
to    O
cancel    O
their    O
performance    O
at    O
the    O
Culture    O
Shock    O
festival    O
on    O
the    O
campus    O
of    O
SUNY    O
Purchase    O
and    O
the    O
first    O
two    O
dates    O
on    O
their    O
2010    O
US    O
tour    O
,    O
as    O
they    O
were    O
unable    O
to    O
get    O
out    O
of    O
Britain    O
due    O
to    O
the    O
air    O
travel    O
delays    O
from    O
the    O
aftermath    O
of    O
the    O
2010    B-VolcanicEruption107436475
eruptions    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Icelandic    I-VolcanicEruption107436475
volcano    I-VolcanicEruption107436475
Eyjafjallajökull    I-VolcanicEruption107436475
.    O

In    O
April    O
2010    O
,    O
Gosling    O
was    O
at    O
Heathrow    O
Airport    O
reporting    O
on    O
the    O
events    O
surrounding    O
the    O
air    O
travel    O
disruption    O
following    O
the    O
eruption    B-VolcanicEruption107436475
of    O
Eyjafjallajökull    O
which    O
forced    O
the    O
closure    O
of    O
airspace    O
throughout    O
much    O
of    O
northern    O
Europe    O
.    O

2010    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Eyjafjallajökull    I-VolcanicEruption107436475
–    O
A    O
massive    O
ash    O
cloud    O
is    O
formed    O
by    O
the    O
eruption    O
of    O
the    O
Icelandic    O
volcano    O
Eyjafjallajökull    O
,    O
on    O
April    O
14    O
,    O
2010    O
,    O
grounding    O
flights    O
across    O
northwest    O
Europe    O
.    O

On    O
19    O
April    O
2010    O
,    O
it    O
was    O
announced    O
that    O
the    O
Japanese    O
Grand    O
Prix    O
would    O
be    O
moved    O
from    O
25    O
April    O
to    O
3    O
October    O
,    O
due    O
to    O
the    O
disruption    O
to    O
air    O
travel    O
after    O
the    O
second    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    O
the    O
Eyjafjallajökull    O
volcano    O
in    O
Iceland    O
.    O

He    O
was    O
also    O
offered    O
a    O
trial    O
with    O
Newcastle    O
,    O
but    O
due    O
to    O
the    O
Icelandic    B-VolcanicEruption107436475
volcanic    I-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
2010    I-VolcanicEruption107436475
,    O
he    O
had    O
to    O
travel    O
for    O
4    O
days    O
to    O
reach    O
England    O
.    O

In    O
2010    O
,    O
Iceland    O
's    O
Eyjafjallajökull    B-VolcanicEruption107436475
volcano    I-VolcanicEruption107436475
erupted    I-VolcanicEruption107436475
,    O
causing    O
significant    O
disruption    O
of    O
air    O
travel    O
throughout    O
Europe    O
,    O
and    O
the    O
EU    O
responded    O
by    O
announcing    O
that    O
it    O
would    O
issue    O
visas    O
at    O
land    O
borders    O
to    O
stranded    O
travelers    O
.    O

The    O
series    O
,    O
including    O
its    O
title    O
,    O
is    O
inspired    O
by    O
Iceland    O
's    O
tourism    O
boom    O
,    O
following    O
the    O
2010    B-VolcanicEruption107436475
eruptions    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Eyjafjallajökull    I-VolcanicEruption107436475
.    O

Major    O
disruptions    O
to    O
air    O
travel    O
in    O
the    O
21st    O
Century    O
included    O
the    O
closing    O
of    O
U.S.    O
airspace    O
following    O
the    O
September    O
11    O
attacks    O
,    O
and    O
the    O
closing    O
of    O
northern    O
European    O
airspace    O
after    O
the    O
2010    B-VolcanicEruption107436475
eruptions    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Eyjafjallajökull    I-VolcanicEruption107436475
.    O

He    O
described    O
the    O
closure    O
of    O
European    O
airspace    O
in    O
April    O
2010    O
over    O
worries    O
about    O
the    O
ash    O
plume    O
from    O
an    O
erupting    B-VolcanicEruption107436475
Icelandic    I-VolcanicEruption107436475
volcano    I-VolcanicEruption107436475
as    O
a    O
"    O
gross    O
over    O
-    O
reaction    O
to    O
a    O
very    O
minor    O
risk    O
"    O
.    O

The    O
ash    O
produced    O
by    O
the    O
2010    B-VolcanicEruption107436475
eruptions    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Eyjafjallajökull    I-VolcanicEruption107436475
led    O
to    O
some    O
customers    O
waiting    O
a    O
month    O
getting    O
their    O
HTC    O
Desires    O
due    O
to    O
much    O
of    O
European    O
airspace    O
being    O
closed    O
.    O

The    O
Australian    O
release    O
was    O
delayed    O
until    O
22    O
June    O
2010    O
,    O
due    O
to    O
European    O
supply    O
problems    O
caused    O
by    O
the    O
economic    O
effects    O
of    O
the    O
2010    B-VolcanicEruption107436475
eruptions    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Eyjafjallajökull    I-VolcanicEruption107436475
.    O

Tropical    B-VolcanicEruption107436475
acne    I-VolcanicEruption107436475
is    O
unusually    O
severe    O
acne    O
occurring    O
in    O
the    O
tropics    O
during    O
seasons    O
when    O
the    O
weather    O
is    O
hot    O
and    O
humid    O
.    O

Sulfonamide    B-VolcanicEruption107436475
hypersensitivity    I-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475

Drug-induced    B-VolcanicEruption107436475
acne    I-VolcanicEruption107436475

Lichen    B-VolcanicEruption107436475
verrucosus    I-VolcanicEruption107436475
et    I-VolcanicEruption107436475
reticularis    I-VolcanicEruption107436475
is    O
a    O
cutaneous    O
condition    O
that    O
may    O
be    O
related    O
to    O
keratosis    B-VolcanicEruption107436475
lichenoides    I-VolcanicEruption107436475
chronica    I-VolcanicEruption107436475
.    O

Stevens–Johnson    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
(    O
Erythema    B-VolcanicEruption107436475
multiforme    I-VolcanicEruption107436475
major    I-VolcanicEruption107436475
)    O

Perifolliculitis    B-VolcanicEruption107436475
capitis    I-VolcanicEruption107436475
abscedens    I-VolcanicEruption107436475

Oil    B-VolcanicEruption107436475
acne    I-VolcanicEruption107436475

Cutaneous    B-VolcanicEruption107436475
small-vessel    I-VolcanicEruption107436475
vasculitis    I-VolcanicEruption107436475
,    O
also    O
known    O
as    O
hypersensitivity    B-VolcanicEruption107436475
vasculitis    I-VolcanicEruption107436475
,    O
cutaneous    B-VolcanicEruption107436475
leukocytoclastic    I-VolcanicEruption107436475
vasculitis    I-VolcanicEruption107436475
,    O
hypersensitivity    B-VolcanicEruption107436475
angiitis    I-VolcanicEruption107436475
,    O
cutaneous    B-VolcanicEruption107436475
leukocytoclastic    I-VolcanicEruption107436475
angiitis    I-VolcanicEruption107436475
,    O
cutaneous    B-VolcanicEruption107436475
necrotizing    I-VolcanicEruption107436475
vasculitis    I-VolcanicEruption107436475
and    O
cutaneous    B-VolcanicEruption107436475
necrotizing    I-VolcanicEruption107436475
venulitis    I-VolcanicEruption107436475
,    O
is    O
inflammation    O
of    O
small    O
blood    O
vessels    O
(    O
usually    O
post    O
-    O
capillary    O
venules    O
in    O
the    O
dermis    O
)    O
,    O
characterized    O
by    O
palpable    O
purpura    O
.    O

Cutaneous    B-VolcanicEruption107436475
small-vessel    I-VolcanicEruption107436475
vasculitis    I-VolcanicEruption107436475

Cutaneous    B-VolcanicEruption107436475
small-vessel    I-VolcanicEruption107436475
vasculitis    I-VolcanicEruption107436475

Cutaneous    B-VolcanicEruption107436475
small-vessel    I-VolcanicEruption107436475
vasculitis    I-VolcanicEruption107436475

Acetylated    O
lanolin    O
alcohol    O
is    O
used    O
as    O
an    O
emollient    O
,    O
to    O
soften    O
skin    O
,    O
but    O
is    O
mildly    O
comedogenic    B-VolcanicEruption107436475
,    O
with    O
a    O
rating    O
of    O
0    O
-    O
2    O
out    O
of    O
5    O
.    O

Acne    B-VolcanicEruption107436475
cosmetica    I-VolcanicEruption107436475
(    O
cosmetic    O
acne    O
)    O

Drug    B-VolcanicEruption107436475
photoallergic    I-VolcanicEruption107436475
response    I-VolcanicEruption107436475

Acne    B-VolcanicEruption107436475
aestivalis    I-VolcanicEruption107436475
(    O
Mallorca    O
acne    O
)    O

Steroid    B-VolcanicEruption107436475
rosacea    I-VolcanicEruption107436475

Hydroxyurea    B-VolcanicEruption107436475
dermopathy    I-VolcanicEruption107436475
is    O
caused    O
by    O
chronic    O
use    O
of    O
hydroxyurea    O
for    O
chronic    O
myelogenous    O
leukemia    O
,    O
thrombocytosis    O
,    O
or    O
psoriasis    O
,    O
and    O
presents    O
with    O
skin    O
lesions    O
characteristic    O
of    O
dermatomyositis    O
.    O

Infantile    B-VolcanicEruption107436475
acne    I-VolcanicEruption107436475

Halogen    B-VolcanicEruption107436475
acne    I-VolcanicEruption107436475

Gram-negative    B-VolcanicEruption107436475
folliculitis    I-VolcanicEruption107436475

Rare    O
complications    O
from    O
acne    O
or    O
its    O
treatment    O
include    O
the    O
formation    O
of    O
pyogenic    O
granulomas    O
,    O
osteoma    O
cutis    O
,    O
and    O
solid    B-VolcanicEruption107436475
facial    I-VolcanicEruption107436475
edema    I-VolcanicEruption107436475
.    O

Hidradenitis    B-VolcanicEruption107436475
suppurativa    I-VolcanicEruption107436475

In    O
July    O
2015    O
,    O
while    O
Jimmy    O
Fallon    O
was    O
recovering    O
from    O
surgery    O
after    O
suffering    O
a    O
serious    O
injury    O
to    O
his    O
finger    O
,    O
Higgins    O
was    O
hospitalized    O
for    O
Hidradenitis    B-VolcanicEruption107436475
Suppurativa    I-VolcanicEruption107436475
.    O

Boils    O
which    O
recur    O
under    O
the    O
arm    O
,    O
breast    O
or    O
in    O
the    O
groin    O
area    O
may    O
be    O
associated    O
with    O
hidradenitis    B-VolcanicEruption107436475
suppurativa    I-VolcanicEruption107436475
(    O
HS    O
)    O
.    O

There    O
are    O
several    O
other    O
medical    O
terms    O
associated    O
with    O
his    O
name    O
,    O
however    O
these    O
terms    O
are    O
now    O
primarily    O
used    O
for    O
historical    O
purposes    O
only    O
;    O
these    O
include    O
:    O
"    O
Velpeau    O
hernia    O
"    O
for    O
the    O
femoral    O
hernia    O
,    O
"    O
Velpeau    O
's    O
disease    O
"    O
for    O
hidradenitis    B-VolcanicEruption107436475
suppurativa    I-VolcanicEruption107436475
,    O
"    O
Velpeau    O
's    O
canal    O
"    O
for    O
the    O
inguinal    O
canal    O
and    O
"    O
Velpeau    O
's    O
fossa    O
"    O
,    O
also    O
known    O
as    O
the    O
ischiorectal    O
fossa    O
.    O

Contact    O
with    O
its    O
milky    O
sap    O
(    O
latex    O
)    O
produces    O
bullous    B-VolcanicEruption107436475
dermatitis    I-VolcanicEruption107436475
,    O
acute    O
keratoconjunctivitis    O
and    O
possibly    O
large    O
corneal    O
epithelial    O
defects    O
.    O

A    O
series    O
of    O
earthquakes    O
inside    O
Long    O
Valley    O
Caldera    O
,    O
coincidentally    O
starting    O
two    O
weeks    O
after    O
the    O
May    O
1980    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
in    O
Washington    O
,    O
alerted    O
geologists    O
to    O
the    O
possibility    O
of    O
renewed    O
volcanic    O
activity    O
in    O
the    O
region    O
.    O

Mount    O
Mazama    O
,    O
once    O
the    O
tallest    O
mountain    O
in    O
the    O
region    O
at    O
11,000    O
feet    O
,    O
had    O
a    O
massive    O
volcanic    O
eruption    O
approximately    O
5677    O
B.C.    O
The    O
eruption    O
,    O
estimated    O
to    O
have    O
been    O
42    O
times    O
more    O
powerful    O
than    O
the    O
1980    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
,    O
reduced    O
Mazama    O
's    O
approximate    O
11,000    O
foot    O
(    O
c.3,350    O
m    O
)    O
height    O
by    O
around    O
half    O
a    O
mile    O
(    O
about    O
1    O
km    O
)    O
when    O
much    O
of    O
the    O
volcano    O
fell    O
into    O
the    O
volcano    O
's    O
partially    O
emptied    O
neck    O
and    O
magma    O
chamber    O
.    O

Away    O
from    O
the    O
fossil    O
record    O
,    O
fern    O
spikes    O
have    O
also    O
been    O
observed    O
to    O
occur    O
in    O
response    O
to    O
local    O
extinction    O
events    O
,    O
for    O
instance    O
the    O
1980    B-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
.    O

May    O
18    O
–    O
Mount    O
St.    O
Helens    O
erupts    B-VolcanicEruption107436475
in    O
Washington    O
,    O
killing    O
57    O
and    O
causing    O
US$    O
3    O
billion    O
in    O
damage    O
.    O

May    O
18    O
:    O
Mount    B-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
erupts    I-VolcanicEruption107436475
.    O

Prior    O
to    O
the    O
1980    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
,    O
the    O
only    O
known    O
fatality    O
related    O
to    O
volcanic    O
activity    O
in    O
the    O
Cascades    O
occurred    O
in    O
1934    O
,    O
when    O
a    O
climber    O
suffocated    O
in    O
oxygen    O
-    O
poor    O
air    O
while    O
exploring    O
ice    O
caves    O
melted    O
by    O
fumaroles    O
in    O
Coalman    O
Glacier    O
on    O
Mount    O
Hood    O
.    O

Mount    B-VolcanicEruption107436475
Saint    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
1980    I-VolcanicEruption107436475

Mount    B-VolcanicEruption107436475
Saint    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
1980    I-VolcanicEruption107436475

It    O
is    O
estimated    O
that    O
the    O
eruption    O
was    O
one    O
thousand    O
times    O
greater    O
than    O
the    O
1980    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
.    O

The    O
Vancouver    O
,    O
Washington    O
store    O
opened    O
just    O
in    O
time    O
for    O
the    O
1980    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
.    O

The    O
river    O
was    O
altered    O
by    O
the    O
1980    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
,    O
a    O
nearby    O
volcano    O
,    O
and    O
subsequent    O
flows    O
of    O
ash    O
and    O
other    O
debris    O
.    O

The    O
eruption    B-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
and    O
subsequent    O
lahars    O
poured    O
vast    O
amounts    O
of    O
sediment    O
into    O
the    O
Toutle    O
.    O

Mount    B-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
erupted    I-VolcanicEruption107436475
two    O
days    O
before    O
the    O
Oregon    O
primaries    O
.    O

After    O
viewing    O
a    O
display    O
claiming    O
that    O
the    O
Grand    O
Canyon    O
could    O
have    O
been    O
carved    O
in    O
a    O
matter    O
of    O
hours    O
by    O
receding    O
flood    O
waters    O
,    O
just    O
as    O
volcanic    O
mudslides    O
carved    O
canyons    O
in    O
softer    O
rock    O
in    O
the    O
aftermath    O
of    O
the    O
1980    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
,    O
chemist    O
William    O
Watkin    O
declared    O
,    O
"    O
Everything    O
they    O
said    O
about    O
sediment    O
deposition    O
,    O
about    O
Mount    O
St.    O
Helens    O
...    O
anyone    O
in    O
first    O
year    O
geology    O
would    O
say    O
'    O
wrong    O
from    O
top    O
to    O
bottom    O
'    O
"    O
.    O

1980    O
–    O
Mount    O
St.    O
Helens    O
erupts    B-VolcanicEruption107436475
in    O
Washington    O
,    O
United    O
States    O
,    O
killing    O
57    O
people    O
and    O
causing    O
$    O
3    O
billion    O
in    O
damage    O
.    O

1980    O
–    O
Victims    O
of    O
Mount    B-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
:    O

Washington    O
's    O
Mount    O
St.    O
Helens    O
erupted    B-VolcanicEruption107436475
in    I-VolcanicEruption107436475
1980    I-VolcanicEruption107436475
,    O
an    O
event    O
visible    O
from    O
northern    O
Oregon    O
and    O
affecting    O
some    O
areas    O
there    O
.    O

One    O
of    O
the    O
explanations    O
advanced    O
for    O
the    O
Valle    O
dei    O
Grigi    O
is    O
that    O
it    O
is    O
the    O
result    O
of    O
the    O
collapse    O
of    O
a    O
sector    O
of    O
the    O
mountain    O
,    O
as    O
occurred    O
during    O
the    O
1980    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
and    O
the    O
1792    O
eruption    O
of    O
Mount    O
Unzen    O
.    O

In    O
terms    O
of    O
natural    O
disaster    O
-    O
related    O
fatalities    O
for    O
the    O
20th    O
century    O
,    O
only    O
Oregon    O
's    O
Heppner    O
Flood    O
of    O
1903    O
(    O
247    O
deaths    O
)    O
,    O
Washington    O
's    O
Wellington    O
avalanche    O
of    O
1910    O
(    O
96    O
deaths    O
)    O
,    O
the    O
Great    O
Fire    O
of    O
1910    O
(    O
87    O
deaths    O
)    O
,    O
and    O
Eruption    B-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
of    O
1980    O
(    O
57    O
deaths    O
)    O
caused    O
more    O
.    O

Billings    O
was    O
affected    O
by    O
the    O
1980    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
in    O
May    O
;    O
the    O
city    O
received    O
about    O
an    O
inch    O
of    O
ash    O
on    O
the    O
ground    O
.    O

The    O
new    O
dome    O
did    O
not    O
rise    O
above    O
the    O
crater    O
created    O
by    O
the    O
1980    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
.    O

During    O
the    O
1980    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Mount    I-VolcanicEruption107436475
St.    I-VolcanicEruption107436475
Helens    I-VolcanicEruption107436475
,    O
lahars    O
(    O
volcanically    O
-    O
induced    O
mud    O
and    O
debris    O
flows    O
)    O
swept    O
through    O
its    O
channel    O
.    O

Drug-induced    B-VolcanicEruption107436475
nail    I-VolcanicEruption107436475
changes    I-VolcanicEruption107436475

Idiopathic    B-VolcanicEruption107436475
eruptive    I-VolcanicEruption107436475
macular    I-VolcanicEruption107436475
pigmentation    I-VolcanicEruption107436475

Adverse    B-VolcanicEruption107436475
reactions    I-VolcanicEruption107436475
to    I-VolcanicEruption107436475
biologic    I-VolcanicEruption107436475
agents    I-VolcanicEruption107436475
,    O
such    O
as    O
imatinib    O
,    O
occur    O
in    O
more    O
than    O
80%    O
of    O
patients    O
,    O
and    O
can    O
be    O
characterized    O
by    O
edema    O
and    O
pruritus    O
without    O
dermatitis    O
.    O

Bromoderma    B-VolcanicEruption107436475
,    O
also    O
known    O
as    O
bromoderma    B-VolcanicEruption107436475
tuberosum    I-VolcanicEruption107436475
,    O
is    O
a    O
dermatological    O
condition    O
characterized    O
by    O
an    O
eruption    O
of    O
papules    O
and    O
pustules    O
on    O
the    O
skin    O
.    O

Lichenoid    B-VolcanicEruption107436475
trikeratosis    I-VolcanicEruption107436475
is    O
a    O
cutaneous    O
condition    O
that    O
may    O
be    O
related    O
to    O
keratosis    B-VolcanicEruption107436475
lichenoides    I-VolcanicEruption107436475
chronica    I-VolcanicEruption107436475
.    O

Halogenoderma    B-VolcanicEruption107436475

Heparin    B-VolcanicEruption107436475
necrosis    I-VolcanicEruption107436475

Ocular    B-VolcanicEruption107436475
rosacea    I-VolcanicEruption107436475
is    O
a    O
manifestation    O
of    O
rosacea    B-VolcanicEruption107436475
that    O
affects    O
the    O
eyes    O
and    O
eyelids    O
.    O

Steroid    B-VolcanicEruption107436475
folliculitis    I-VolcanicEruption107436475

Acné    B-VolcanicEruption107436475
excoriée    I-VolcanicEruption107436475
des    I-VolcanicEruption107436475
jeunes    I-VolcanicEruption107436475
filles    I-VolcanicEruption107436475

This    O
group    O
includes    O
neutrophilic    B-VolcanicEruption107436475
eccrine    I-VolcanicEruption107436475
hidradenitis    I-VolcanicEruption107436475
and    O
recurrent    O
palmoplantar    O
hidradenitis    O
.    O

Metophyma    B-VolcanicEruption107436475

HIV    B-VolcanicEruption107436475
disease-related    I-VolcanicEruption107436475
drug    I-VolcanicEruption107436475
reactions    I-VolcanicEruption107436475
present    O
in    O
HIV    O
-    O
infected    O
patients    O
,    O
especially    O
those    O
with    O
helper    O
T    O
-    O
cell    O
counts    O
between    O
25    O
and    O
200    O
,    O
immunosuppression    O
that    O
increases    O
the    O
risk    O
for    O
the    O
development    O
of    O
adverse    O
reactions    O
to    O
medications    O
.    O

H-3    O
,    O
the    O
Hekla    B-VolcanicEruption107436475
3    I-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
,    O
a    O
huge    O
volcanic    O
eruption    O
around    O
1000    O
BC    O

The    O
Hekla    B-VolcanicEruption107436475
3    I-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
approximately    O
coincides    O
with    O
this    O
period    O
,    O
and    O
while    O
the    O
exact    O
date    O
is    O
under    O
considerable    O
dispute    O
,    O
one    O
group    O
calculated    O
the    O
date    O
to    O
be    O
specifically    O
1159    O
BC    O
,    O
implicating    O
the    O
eruption    O
in    O
the    O
collapse    O
in    O
Egypt    O
.    O

Perioral    B-VolcanicEruption107436475
dermatitis    I-VolcanicEruption107436475

Perioral    B-VolcanicEruption107436475
dermatitis    I-VolcanicEruption107436475
refers    O
to    O
a    O
red    O
bumpy    O
rash    O
around    O
the    O
mouth    O
.    O

The    O
most    O
massive    O
supervolcano    O
eruption    O
was    O
the    O
Toba    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
that    O
took    O
place    O
at    O
the    O
present    O
location    O
of    O
Lake    O
Toba    O
,    O
about    O
Before    O
Present    O
.    O

According    O
to    O
Tyson    O
,    O
civilizations    O
can    O
be    O
wiped    O
out    O
by    O
cosmic    O
events    O
like    O
supernovae    O
,    O
natural    O
disasters    O
such    O
as    O
the    O
Toba    B-VolcanicEruption107436475
disaster    I-VolcanicEruption107436475
,    O
or    O
even    O
self    O
-    O
destruct    O
through    O
war    O
or    O
other    O
means    O
,    O
making    O
probability    O
estimates    O
difficult    O
.    O

(    O
see    O
Toba    B-VolcanicEruption107436475
catastrophe    I-VolcanicEruption107436475
theory    I-VolcanicEruption107436475
)    O

Anatomically    O
modern    O
humans    O
appear    O
from    O
about    O
200,000    O
years    O
ago    O
and    O
after    O
70,000    O
years    O
ago    O
(    O
see    O
Toba    B-VolcanicEruption107436475
catastrophe    I-VolcanicEruption107436475
theory    I-VolcanicEruption107436475
)    O
,    O
gradually    O
supplanting    O
the    O
"    O
archaic    O
"    O
human    O
varieties    O
.    O

The    O
massive    O
eruption    O
of    O
Toba    O
supervolcano    O
that    O
occurred    O
some    O
time    O
between    O
69,000    O
and    O
77,000    O
years    O
ago    O
instigated    O
the    O
Toba    B-VolcanicEruption107436475
catastrophe    I-VolcanicEruption107436475
theory    I-VolcanicEruption107436475
,    O
a    O
global    O
volcanic    O
winter    O
that    O
caused    O
a    O
bottleneck    O
in    O
human    O
evolution    O
.    O

According    O
to    O
the    O
Toba    B-VolcanicEruption107436475
catastrophe    I-VolcanicEruption107436475
theory    I-VolcanicEruption107436475
,    O
70    O
to    O
75    O
thousand    O
years    O
ago    O
,    O
a    O
supervolcanic    O
event    O
at    O
Lake    O
Toba    O
reduced    O
the    O
human    O
population    O
to    O
10,000    O
or    O
even    O
1,000    O
breeding    O
pairs    O
,    O
creating    O
a    O
bottleneck    O
in    O
human    O
evolution    O
.    O

In    O
the    O
beginning    O
of    O
the    O
last    O
ice    O
age    O
a    O
supervolcano    B-VolcanicEruption107436475
erupted    O
in    O
Indonesia    O
sometime    O
between    O
75000    O
-    O
70000    O
BP    O
.    O

Exudative    B-VolcanicEruption107436475
hyponychial    I-VolcanicEruption107436475
dermatitis    I-VolcanicEruption107436475
is    O
a    O
nail    O
toxicity    O
common    O
during    O
chemotherapy    O
for    O
breast    O
cancer    O
,    O
especially    O
if    O
docetaxel    O
is    O
the    O
chemotherapeutic    O
regimen    O
.    O

It    O
is    O
a    O
semisynthetic    O
glycopeptide    O
antibiotic    O
with    O
a    O
spectrum    O
of    O
activity    O
similar    O
to    O
vancomycin    B-VolcanicEruption107436475
.    O

Current    O
drug    O
treatments    O
for    O
this    O
infection    O
involve    O
orally    O
delivered    O
antibiotics    O
,    O
principally    O
fidaxomicin    O
,    O
metronidazole    O
and    O
vancomycin    B-VolcanicEruption107436475
;    O
the    O
last    O
two    O
drugs    O
are    O
the    O
principal    O
therapeutic    O
agents    O
in    O
use    O
,    O
but    O
fail    O
in    O
approximately    O
20    O
to    O
45%    O
of    O
the    O
cases    O
.    O

prophylactic    O
delivery    O
of    O
the    O
antibiotic    O
vancomycin    B-VolcanicEruption107436475
into    O
the    O
central    O
nervous    O
system    O
when    O
applied    O
to    O
the    O
surface    O
of    O
the    O
brain    O
after    O
brain    O
surgery    O

Vancomycin    B-VolcanicEruption107436475
or    O
metronidazole    O
if    O
severe    O

Vancomycin    B-VolcanicEruption107436475

Vancomycin    B-VolcanicEruption107436475
for    O
Methicillin    O
-    O
resistant    O
(    O
MRSA    O
)    O

Vancomycin    B-VolcanicEruption107436475

Bottromycin    O
is    O
structurally    O
distinct    O
from    O
both    O
vancomycin    B-VolcanicEruption107436475
,    O
a    O
glycopeptide    O
antibiotic    O
,    O
and    O
methicillin    O
,    O
a    O
beta    O
-    O
lactam    O
antibiotic    O
.    O

SHN    O
strains    O
seems    O
to    O
have    O
thickened    O
cell    O
walls    O
,    O
which    O
can    O
be    O
the    O
result    O
of    O
a    O
genetic    O
background    O
that    O
also    O
allows    O
for    O
vancomycin    B-VolcanicEruption107436475
resistance    O
.    O

Chloramphenicol    O
,    O
vancomycin    B-VolcanicEruption107436475
,    O
streptomycin    O
were    O
all    O
found    O
to    O
completely    O
inhibit    O
growth    O
,    O
though    O
it    O
was    O
resistant    O
to    O
rifampin    O
.    O

Mice    O
exposed    O
to    O
subtherapeutic    O
antibiotic    O
treatment    O
(    O
STAT)–    O
with    O
either    O
penicillin    O
,    O
vancomycin    B-VolcanicEruption107436475
,    O
or    O
chlortetracycline    O
had    O
altered    O
composition    O
of    O
the    O
gut    O
microbiota    O
as    O
well    O
as    O
its    O
metabolic    O
capabilities    O
.    O

It    O
is    O
sometimes    O
used    O
in    O
combination    O
with    O
other    O
antibiotics    O
that    O
have    O
different    O
mechanisms    O
of    O
action    O
,    O
like    O
vancomycin    B-VolcanicEruption107436475
,    O
linezolid    O
,    O
daptomycin    O
,    O
and    O
tigecycline    O
.    O

This    O
left    O
vancomycin    B-VolcanicEruption107436475
as    O
the    O
only    O
effective    O
agent    O
available    O
at    O
the    O
time    O
.    O

'    O
"    O
Vancomycin    B-VolcanicEruption107436475
-    O
resistant    O
"    O
Staphylococcus    O
aureus    O
are    O
strains    O
of    O
"    O
Staphylococcus    O
aureus    O
"    O
that    O
have    O
become    O
resistant    O
to    O
the    O
glycopeptide    O
antibiotic    O
vancomycin    B-VolcanicEruption107436475
.    O

VRSA    O
strain    O
acquired    O
the    O
vancomycin    B-VolcanicEruption107436475
resistance    O
gene    O
cluster    O
"    O
vanA    O
"    O
from    O
VRE    O
.    O

For    O
isolates    O
with    O
a    O
Vancomycin    B-VolcanicEruption107436475
MIC    O
,    O
an    O
alternative    O
to    O
Vancomycin    B-VolcanicEruption107436475
should    O
be    O
used    O
.    O

Vancomycin    B-VolcanicEruption107436475

These    O
produce    O
epoxyquinomicin    O
C    O
,    O
a    O
weak    O
antibiotic    O
and    O
anti    O
-    O
inflammatory    O
agent    O
,    O
and    O
vancomycin    B-VolcanicEruption107436475
,    O
an    O
antibiotic    O
used    O
for    O
infections    O
resistant    O
to    O
other    O
antibiotics    O
.    O

That    O
effect    O
is    O
similar    O
to    O
that    O
of    O
vancomycin    B-VolcanicEruption107436475
,    O
but    O
8    O
to    O
64    O
times    O
greater    O
than    O
that    O
of    O
tetracycline    O
.    O

Antibiotics    O
effective    O
against    O
"    O
Listeria    O
"    O
species    O
include    O
ampicillin    O
,    O
vancomycin    B-VolcanicEruption107436475
,    O
ciprofloxacin    O
and    O
azithromycin    O
.    O

"    O
Stachys    O
byzantina    O
"    O
extract    O
has    O
shown    O
antimicrobial    O
activity    O
against    O
"    O
Staphylococcus    O
aureus    O
"    O
that    O
is    O
resistant    O
to    O
vancomycin    B-VolcanicEruption107436475
.    O

Vancomycin    B-VolcanicEruption107436475
is    O
produced    O
by    O
Streptomyces    O
orientalis    O
,    O
now    O
known    O
as    O
"    O
Amycolatopsis    O
orientalis    O
.    O
"    O

For    O
example    O
,    O
the    O
"    O
Masquelet    O
procedure    O
"    O
consists    O
of    O
initially    O
using    O
PMMA    O
mixed    O
with    O
an    O
antibiotic    O
(    O
vancomycin    B-VolcanicEruption107436475
or    O
gentamicin    O
)    O
for    O
4–12    O
weeks    O
,    O
and    O
then    O
replacing    O
the    O
space    O
with    O
an    O
autologous    O
bone    O
graft    O
.    O

Some    O
severe    O
skin    O
reactions    O
have    O
been    O
reported    O
rarely    O
,    O
including    O
toxic    O
epidermal    O
necrolysis    O
and    O
Stevens-Johnson    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
;    O
causal    O
relationship    O
has    O
not    O
been    O
established    O
.    O

Some    O
severe    O
skin    O
reactions    O
have    O
been    O
reported    O
rarely    O
,    O
including    O
toxic    O
epidermal    O
necrolysis    O
and    O
Stevens-Johnson    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
;    O
causal    O
relationship    O
has    O
not    O
been    O
established    O
.    O

#    O
Hypersensitivity    O
reactions    O
,    O
including    O
Stevens-Johnson    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
in    O
some    O
cases    O

Spironolactone    O
may    O
rarely    O
cause    O
more    O
severe    O
side    O
effects    O
such    O
as    O
anaphylaxis    O
,    O
renal    O
failure    O
,    O
hepatitis    O
(    O
two    O
reported    O
cases    O
,    O
neither    O
serious    O
)    O
,    O
agranulocytosis    O
,    O
DRESS    O
syndrome    O
,    O
Stevens-Johnson    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
or    O
toxic    B-VolcanicEruption107436475
epidermal    I-VolcanicEruption107436475
necrolysis    I-VolcanicEruption107436475
.    O

There    O
have    O
been    O
scattered    O
reports    O
of    O
various    O
problems    O
when    O
the    O
oral    O
form    O
is    O
used    O
,    O
including    O
:    O
problems    O
caused    O
by    O
myelosuppression    O
(    O
leukopenia    O
,    O
neutropenia    O
,    O
agranulocytosis    O
,    O
aplastic    O
anaemia    O
,    O
and    O
thrombocytopenia    O
)    O
,    O
as    O
well    O
as    O
hair    O
loss    O
,    O
peripheral    O
neuropathy    O
,    O
pancreatitis    O
,    O
liver    O
problems    O
,    O
myocarditis    O
and    O
pericarditis    O
,    O
allergic    O
and    O
fibrotic    O
lung    O
reactions    O
,    O
lupus    O
erythematosus    O
-    O
like    O
reactions    O
and    O
rash    O
(    O
including    O
urticaria    O
)    O
,    O
drug    O
fever    O
,    O
interstitial    O
nephritis    O
and    O
nephrotic    O
syndrome    O
,    O
usually    O
reversible    O
on    O
withdrawal    O
.    O
Very    O
rarely    O
,    O
use    O
of    O
mesalazine    O
has    O
been    O
associated    O
with    O
an    O
exacerbation    O
of    O
the    O
symptoms    O
of    O
colitis    O
,    O
Stevens    B-VolcanicEruption107436475
Johnson    I-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
and    O
erythema    O
multiforme    O
.    O

Stevens–Johnson    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475

Stevens-Johnson    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475

A    O
rare    O
adverse    O
reaction    O
to    O
barbiturates    O
is    O
Stevens-Johnson    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
,    O
which    O
primarily    O
affects    O
the    O
mucous    O
membranes    O
.    O

A    O
in    O
PTGER3    O
has    O
been    O
associated    O
with    O
Aspirin    O
-    O
induced    O
asthma    O
in    O
a    O
Korean    O
population    O
;    O
and    O
6    O
SNP    O
variants    O
have    O
been    O
associated    O
with    O
development    O
of    O
the    O
Steven    B-VolcanicEruption107436475
Johnson    I-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
and    O
its    O
more    O
severe    O
form    O
,    O
toxic    B-VolcanicEruption107436475
epidermal    I-VolcanicEruption107436475
necrolysis    I-VolcanicEruption107436475
,    O
in    O
a    O
Japanese    O
population    O
.    O

As    O
a    O
young    O
boy    O
who    O
was    O
4    O
years    O
old    O
he    O
was    O
affected    O
by    O
the    O
Steven    B-VolcanicEruption107436475
Johnson    I-VolcanicEruption107436475
Syndrome    I-VolcanicEruption107436475
and    O
lost    O
his    O
vision    O
completely    O
.    O

The    O
drugs    O
have    O
serious    O
side    O
-    O
effects    O
including    O
hypersensitivity    O
skin    O
reactions    O
with    O
necrosis    O
of    O
the    O
skin    O
,    O
toxic    O
epidermal    O
necrolysis    O
and    O
Stevens-Johnson    B-VolcanicEruption107436475
Syndrome    I-VolcanicEruption107436475
.    O

More    O
severe    O
side    O
effects    O
may    O
include    O
Stevens-Johnson    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
or    O
low    O
blood    O
platelets    O
.    O

Chloracne    B-VolcanicEruption107436475
,    O
due    O
to    O
exposure    O
to    O
certain    O
chemicals    O
,    O
may    O
look    O
very    O
similar    O
to    O
acne    O
vulgaris    O
.    O

Direct    O
skin    O
contact    O
results    O
in    O
a    O
severe    O
acne    O
-    O
like    O
condition    O
called    O
chloracne    B-VolcanicEruption107436475
.    O

The    O
stability    O
of    O
halocarbons    O
tended    O
to    O
encourage    O
beliefs    O
that    O
they    O
were    O
mostly    O
harmless    O
,    O
although    O
in    O
the    O
mid-1920s    O
physicians    O
reported    O
workers    O
in    O
polychlorinated    O
naphthalene    O
manufacturing    O
suffering    O
from    O
chloracne    B-VolcanicEruption107436475
,    O
and    O
by    O
the    O
late    O
1930s    O
it    O
was    O
known    O
that    O
workers    O
exposed    O
to    O
PCNs    O
could    O
die    O
from    O
liver    O
disease    O
and    O
that    O
DDT    O
would    O
kill    O
mosquitos    O
and    O
other    O
insects    O
.    O

Dioxins    O
have    O
been    O
associated    O
with    O
several    O
adverse    O
effects    O
in    O
humans    O
,    O
including    O
immune    O
and    O
enzyme    O
disorders    O
,    O
chloracne    B-VolcanicEruption107436475
,    O
and    O
are    O
classified    O
as    O
a    O
possible    O
human    O
carcinogen    O
.    O

Chloracne    B-VolcanicEruption107436475
is    O
an    O
acne    O
-    O
like    O
eruption    O
of    O
blackheads    O
,    O
cysts    O
,    O
and    O
pustules    O
associated    O
with    O
over    O
-    O
exposure    O
to    O
certain    O
halogenated    O
aromatic    O
compounds    O
,    O
such    O
as    O
chlorinated    O
dioxins    O
and    O
dibenzofurans    O
.    O

Acne    B-VolcanicEruption107436475
varioliformis    I-VolcanicEruption107436475

Iododermas    B-VolcanicEruption107436475
are    O
caused    O
by    O
iodides    O
,    O
with    O
the    O
most    O
common    O
sources    O
of    O
exposure    O
being    O
oral    O
and    O
intravenous    O
contrast    O
materials    O
used    O
to    O
treat    O
thyroid    O
disease    O
.    O

Severe    O
side    O
effects    O
include    O
allergic    O
reactions    O
,    O
liver    O
problems    O
,    O
and    O
skin    O
rashes    O
such    O
as    O
toxic    B-VolcanicEruption107436475
epidermal    I-VolcanicEruption107436475
necrolysis    I-VolcanicEruption107436475
.    O

Johnson    O
syndrome    O
and    O
toxic    B-VolcanicEruption107436475
epidermal    I-VolcanicEruption107436475
necrolysis    I-VolcanicEruption107436475
.    O

Toxic    B-VolcanicEruption107436475
epidermal    I-VolcanicEruption107436475
necrolysis    I-VolcanicEruption107436475

Spironolactone    O
may    O
rarely    O
cause    O
more    O
severe    O
side    O
effects    O
such    O
as    O
anaphylaxis    O
,    O
renal    O
failure    O
,    O
hepatitis    O
(    O
two    O
reported    O
cases    O
,    O
neither    O
serious    O
)    O
,    O
agranulocytosis    O
,    O
DRESS    O
syndrome    O
,    O
Stevens-Johnson    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
or    O
toxic    B-VolcanicEruption107436475
epidermal    I-VolcanicEruption107436475
necrolysis    I-VolcanicEruption107436475
.    O

Johnson    O
syndrome    O
,    O
toxic    B-VolcanicEruption107436475
epidermal    I-VolcanicEruption107436475
necrolysis    I-VolcanicEruption107436475
and/or    O
anaphylaxis    O
.    O

Toxic    B-VolcanicEruption107436475
epidermal    I-VolcanicEruption107436475
necrolysis    I-VolcanicEruption107436475
(    O
Lyell    O
)    O

It    O
was    O
officially    O
declared    O
that    O
he    O
died    O
from    O
an    O
allergic    O
Lyell's    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
.    O

Toxic    B-VolcanicEruption107436475
epidermal    I-VolcanicEruption107436475
necrolysis    I-VolcanicEruption107436475

Johnson    O
syndrome    O
/    O
toxic    B-VolcanicEruption107436475
epidermal    I-VolcanicEruption107436475
necrolysis    I-VolcanicEruption107436475
,    O
although    O
these    O
reactions    O
are    O
very    O
rare    O
.    O

A    O
in    O
PTGER3    O
has    O
been    O
associated    O
with    O
Aspirin    O
-    O
induced    O
asthma    O
in    O
a    O
Korean    O
population    O
;    O
and    O
6    O
SNP    O
variants    O
have    O
been    O
associated    O
with    O
development    O
of    O
the    O
Steven    B-VolcanicEruption107436475
Johnson    I-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
and    O
its    O
more    O
severe    O
form    O
,    O
toxic    B-VolcanicEruption107436475
epidermal    I-VolcanicEruption107436475
necrolysis    I-VolcanicEruption107436475
,    O
in    O
a    O
Japanese    O
population    O
.    O

Johnson    O
syndrome    O
and    O
toxic    B-VolcanicEruption107436475
epidermal    I-VolcanicEruption107436475
necrolysis    I-VolcanicEruption107436475
,    O
eye    O
problems    O
(    O
uveitis    O
,    O
scleritis    O
)    O
and    O
generalized    O
muscle    O
,    O
joint    O
,    O
and    O
bone    O
pain    O
(    O
rarely    O
severe    O
)    O
have    O
been    O
seen    O
.    O

Johnson    O
syndrome    O
,    O
toxic    B-VolcanicEruption107436475
epidermal    I-VolcanicEruption107436475
necrolysis    I-VolcanicEruption107436475
and    O
erythema    O
multiforme    O
,    O
as    O
well    O
as    O
hypersensitivity    O
reactions    O
characterized    O
by    O
rash    O
,    O
constitutional    O
findings    O
,    O
and    O
sometimes    O
organ    O
dysfunction    O
,    O
including    O
liver    O
failure    O
.    O

PAPA    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475

PAPA    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
is    O
an    O
acronym    O
for    O
pyogenic    O
arthritis    O
,    O
pyoderma    O
gangrenosum    O
and    O
acne    O
.    O

Occupational    B-VolcanicEruption107436475
acne    I-VolcanicEruption107436475

Eruptions    O
in    O
the    O
ultra    O
-    O
Plinian    O
category    O
include    O
Lake    B-VolcanicEruption107436475
Toba    I-VolcanicEruption107436475
(    O
approx    O
74000    O
years    O
ago    O
,    O
VEI    O
8)    O
,    O
Tambora    O
(    O
1815    O
,    O
VEI    O
7    O
)    O
,    O
Krakatoa    B-VolcanicEruption107436475
(    O
1883    O
,    O
VEI    O
6    O
)    O
,    O
Akahoya    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    O
Kikai    O
Caldera    O
,    O
Japan    O
,    O
and    O
the    O
1991    O
Mount    O
Pinatubo    O
eruption    O
in    O
the    O
Philippines    O
(    O
VEI    O
6    O
)    O
.    O

Pomade    B-VolcanicEruption107436475
acne    I-VolcanicEruption107436475

This    O
was    O
one    O
of    O
the    O
largest    O
and    O
most    O
violent    O
eruptions    O
in    O
the    O
last    O
5,000    O
years    O
(    O
alongside    O
the    O
Hatepe    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    O
Lake    O
Taupo    O
at    O
around    O
180    O
AD    O
and    O
the    O
1815    O
eruption    O
of    O
Tambora    O
)    O
.    O

The    O
Millennium    O
eruption    O
was    O
one    O
of    O
the    O
largest    O
and    O
most    O
violent    O
eruptions    O
of    O
the    O
last    O
5000    O
years    O
(    O
alongside    O
the    O
Hatepe    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
of    O
Lake    O
Taupo    O
at    O
around    O
180    O
AD    O
and    O
the    O
1815    O
eruption    O
of    O
Tambora    O
,    O
which    O
had    O
a    O
Volcanic    O
Explosivity    O
Index    O
rating    O
of    O
7    O
)    O
,    O
and    O
it    O
has    O
been    O
recorded    O
in    O
the    O
book    O
of    O
Koryo    O
History    O
.    O

The    O
Hatepe    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
,    O
named    O
for    O
the    O
Hatepe    O
Plinian    O
pumice    O
tephra    O
layer    O
,    O
sometimes    O
referred    O
to    O
as    O
the    O
Taupo    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
and    O
dated    O
to    O
around    O
180    O
AD    O
,    O
was    O
Lake    O
Taupo    O
's    O
most    O
recent    O
major    O
eruption    O
.    O

Infantile    B-VolcanicEruption107436475
acropustulosis    I-VolcanicEruption107436475
(    O
acropustulosis    O
of    O
infancy    O
)    O

"    O
Graft    O
-    O
vs    O
.-    O
host    O
disease    O
-    O
like    O
"    O
:    O
Widespread    O
lichenoid    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
with    O
severe    O
mucous    O
membrane    O
involvement    O

Acne    B-VolcanicEruption107436475
mechanica    I-VolcanicEruption107436475

Leukotriene    B-VolcanicEruption107436475
receptor    I-VolcanicEruption107436475
antagonist-associated    I-VolcanicEruption107436475
Churg–Strauss    I-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475

Pustular    B-VolcanicEruption107436475
bacterid    I-VolcanicEruption107436475

Injection    B-VolcanicEruption107436475
site    I-VolcanicEruption107436475
reaction    I-VolcanicEruption107436475

Side    O
effects    O
in    O
animals    O
include    O
nephrotoxicity    O
,    O
ototoxicity    O
,    O
and    O
allergic    B-VolcanicEruption107436475
reactions    I-VolcanicEruption107436475
at    I-VolcanicEruption107436475
IM    I-VolcanicEruption107436475
injection    I-VolcanicEruption107436475
sites    I-VolcanicEruption107436475
.    O

This    O
makes    O
it    O
one    O
of    O
the    O
most    O
violent    O
eruptions    O
in    O
the    O
last    O
5000    O
years    O
,    O
comparable    O
to    O
the    O
Minoan    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
in    O
the    O
2nd    O
millennium    O
BC    O
,    O
the    O
Tianchi    O
eruption    O
of    O
Baekdu    O
around    O
1000    O
AD    O
and    O
the    O
1815    O
eruption    O
of    O
Tambora    O
.    O

Other    O
eruptions    O
of    O
comparable    O
intensity    O
are    O
the    O
Kurile    O
lake    O
eruption    O
in    O
the    O
7th    O
millennium    O
BC    O
,    O
the    O
Mount    O
Mazama    O
eruption    O
in    O
the    O
6th    O
millennium    O
,    O
the    O
Minoan    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
,    O
and    O
the    O
Tierra    O
Blanca    O
Joven    O
eruption    O
of    O
Ilopango    O
in    O
the    O
6th    O
century    O
.    O

The    O
fact    O
that    O
Plato    O
borrowed    O
some    O
of    O
his    O
other    O
allegories    O
and    O
metaphors    O
—    O
most    O
notably    O
the    O
story    O
of    O
Gyges    O
—    O
from    O
older    O
traditions    O
has    O
caused    O
a    O
number    O
of    O
scholars    O
to    O
investigate    O
possible    O
inspiration    O
of    O
Atlantis    O
from    O
Egyptian    O
records    O
of    O
the    O
Thera    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
,    O
the    O
Sea    O
Peoples    O
invasion    O
,    O
or    O
the    O
Trojan    O
War    O
.    O

The    O
Thera    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
,    O
dated    O
to    O
the    O
seventeenth    O
or    O
sixteenth    O
century    O
BC    O
,    O
caused    O
a    O
large    O
tsunami    O
that    O
some    O
experts    O
hypothesize    O
devastated    O
the    O
Minoan    O
civilization    O
on    O
the    O
nearby    O
island    O
of    O
Crete    O
,    O
further    O
leading    O
some    O
to    O
believe    O
that    O
this    O
may    O
have    O
been    O
the    O
catastrophe    O
that    O
inspired    O
the    O
story    O
.    O

The    O
Thera    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
and    O
the    O
Late    O
Bronze    O
Age    O
collapse    O
affected    O
that    O
area    O
and    O
might    O
have    O
been    O
the    O
devastation    O
to    O
which    O
the    O
sources    O
used    O
by    O
Plato    O
referred    O
.    O

Minoan    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475

From    O
the    O
Minoan    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
event    O
,    O
and    O
the    O
1964    O
discovery    O
of    O
Akrotiri    O
on    O
the    O
island    O
,    O
this    O
location    O
is    O
one    O
of    O
many    O
sites    O
purported    O
to    O
have    O
been    O
the    O
location    O
of    O
Atlantis    O
.    O

The    O
settlement    O
was    O
destroyed    O
in    O
the    O
Theran    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
about    O
1627    O
BC    O
and    O
buried    O
in    O
volcanic    O
ash    O
,    O
which    O
preserved    O
the    O
remains    O
of    O
fine    O
frescoes    O
and    O
many    O
objects    O
and    O
artworks    O
.    O

Akrotiri    O
was    O
buried    O
by    O
the    O
massive    O
Theran    B-VolcanicEruption107436475
eruption    I-VolcanicEruption107436475
in    O
the    O
middle    O
of    O
the    O
second    O
millennium    O
BC    O
(    O
during    O
the    O
Late    O
Minoan    O
IA    O
period    O
)    O
;    O
as    O
a    O
result    O
,    O
like    O
the    O
Roman    O
ruins    O
of    O
Pompeii    O
after    O
it    O
,    O
it    O
is    O
remarkably    O
well    O
-    O
preserved    O
.    O

Primidone    O
is    O
one    O
of    O
the    O
anticonvulsants    O
associated    O
with    O
anticonvulsant    B-VolcanicEruption107436475
hypersensitivity    I-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
,    O
others    O
being    O
carbamazepine    O
,    O
phenytoin    O
,    O
and    O
phenobarbital    O
.    O

Granulomatous    B-VolcanicEruption107436475
facial    I-VolcanicEruption107436475
dermatitis    I-VolcanicEruption107436475

Photoleukomelanodermatitis    B-VolcanicEruption107436475
of    I-VolcanicEruption107436475
Kobori    I-VolcanicEruption107436475

Drug-related    B-VolcanicEruption107436475
gingival    I-VolcanicEruption107436475
hyperplasia    I-VolcanicEruption107436475

Lichen    B-VolcanicEruption107436475
striatus    I-VolcanicEruption107436475
,    O
a    O
self    O
-    O
limited    O
eruption    O
of    O
small    O
,    O
slightly    O
scaly    O
papules    O
,    O
includes    O
a    O
lymphoid    O
infiltrate    O
around    O
eccrine    O
sweat    O
glands    O
.    O

In    O
SAPHO    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475
there    O
may    O
be    O
arthropathy    O
of    O
the    O
sternoclavicular    O
joint    O
.    O

SAPHO    B-VolcanicEruption107436475
syndrome    I-VolcanicEruption107436475

Warfarin    B-VolcanicEruption107436475
necrosis    I-VolcanicEruption107436475

Acrodermatitis    B-VolcanicEruption107436475
continua    I-VolcanicEruption107436475
is    O
a    O
form    O
of    O
localized    O
psoriasis    O
limited    O
to    O
the    O
fingers    O
and    O
toes    O
that    O
may    O
spread    O
to    O
the    O
hands    O
and    O
feet    O
.    O

Steroid    B-VolcanicEruption107436475
acne    I-VolcanicEruption107436475
is    O
an    O
adverse    O
reaction    O
to    O
corticosteroids    O
,    O
and    O
presents    O
as    O
small    O
,    O
firm    O
follicular    O
papules    O
on    O
the    O
forehead    O
,    O
cheeks    O
,    O
and    O
chest    O
.    O

Many    O
skin    O
conditions    O
can    O
mimic    O
acne    O
vulgaris    O
and    O
are    O
collectively    O
known    O
as    O
acneiform    B-VolcanicEruption107436475
eruptions    I-VolcanicEruption107436475
.    O

Acneiform    B-VolcanicEruption107436475
eruptions    I-VolcanicEruption107436475
are    O
a    O
group    O
of    O
dermatoses    O
including    O
acne    O
vulgaris    O
,    O
rosacea    B-VolcanicEruption107436475
,    O
folliculitis    O
,    O
and    O
perioral    B-VolcanicEruption107436475
dermatitis    I-VolcanicEruption107436475
.    O

In    O
the    O
1960s    O
and    O
1970s    O
,    O
the    O
First    O
Nation    O
was    O
severely    O
affected    O
by    O
acute    O
mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475
,    O
known    O
as    O
the    O
Ontario    O
Minamata    O
disease    O
due    O
to    O
mercury    O
contamination    O
affecting    O
the    O
English    O
River    O
.    O

Mercury    O
contamination    O
in    O
California    O
waterways    O
posed    B-VolcanicEruption107436475
a    I-VolcanicEruption107436475
threat    I-VolcanicEruption107436475
to    O
both    O
the    O
environment    O
and    O
human    O
health    O
.    O

Mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475

The    O
mercury    O
,    O
contained    O
in    O
1,857    O
rusting    O
steel    O
bottles    O
located    O
down    O
in    O
the    O
vessel    O
's    O
keel    O
,    O
was    O
found    O
to    O
be    O
leaking    O
out    O
and    O
currently    O
poses    O
a    O
severe    O
environmental    O
threat    O
,    O
from    O
potential    O
mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475
.    O

This    O
reduces    O
risk    O
of    O
mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475
for    O
users    O
and    O
other    O
mercury    O
problems    O
.    O

However    O
,    O
it    O
is    O
now    O
known    O
that    O
exposure    O
to    O
mercury    O
and    O
its    O
compounds    O
causes    O
hydrargyria    O
or    O
mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475
.    O

Mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475

Cachexia    O
is    O
seen    O
in    O
people    O
with    O
cancer    O
,    O
AIDS    O
,    O
coeliac    O
disease    O
,    O
chronic    O
obstructive    O
pulmonary    O
disease    O
,    O
multiple    O
sclerosis    O
,    O
Rheumatoid    O
arthritis    O
,    O
congestive    O
heart    O
failure    O
,    O
tuberculosis    O
,    O
familial    O
amyloid    O
polyneuropathy    O
,    O
mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475
(    O
acrodynia    O
)    O
,    O
Crohn    O
's    O
disease    O
,    O
untreated    O
/    O
severe    O
Type    O
1    O
Diabetes    O
Mellitus    O
,    O
anorexia    O
nervosa    O
,    O
and    O
hormonal    O
deficiency    O
.    O

Mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475
can    O
also    O
lead    O
to    O
Korsakoff    O
's    O
syndrome    O
.    O

Swallowed    O
batteries    O
can    O
be    O
associated    O
with    O
additional    O
damage    O
,    O
with    O
mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475
(    O
from    O
mercury    O
batteries    O
)    O
and    O
lead    O
poisoning    O
(    O
from    O
lead    O
batteries    O
)    O
presenting    O
important    O
risks    O
.    O

Mercury    O
cells    O
are    O
being    O
phased    O
out    O
due    O
to    O
concerns    O
about    O
mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475
from    O
mercury    O
cell    O
pollution    O
such    O
as    O
occurred    O
in    O
Canada    O
(    O
see    O
Ontario    O
Minamata    O
disease    O
)    O
and    O
Japan    O
(    O
see    O
Minamata    O
disease    O
)    O
.    O

His    O
most    O
famous    O
work    O
covered    O
the    O
effects    O
of    O
Minamata    O
disease    O
,    O
a    O
type    O
of    O
severe    O
mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475
that    O
occurred    O
in    O
the    O
city    O
of    O
Minamata    O
,    O
Kumamoto    O
Prefecture    O
during    O
the    O
1950s    O
and    O
1960s    O
.    O

The    O
toxic    O
solutions    O
from    O
the    O
carrot    O
and    O
the    O
vapours    O
it    O
produced    O
resulted    O
in    O
widespread    O
cases    O
of    O
mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475
among    O
hatters    O
.    O

These    O
children    O
and    O
families    O
suffer    O
chronic    O
exposure    O
to    O
toxic    O
chemicals    O
including    O
mercury    B-VolcanicEruption107436475
,    O
and    O
do    O
hazardous    O
work    O
such    O
as    O
digging    O
shafts    O
and    O
working    O
underground    O
,    O
pulling    O
up    O
,    O
carrying    O
and    O
crushing    O
the    O
ore    O
.    O

mercury    B-VolcanicEruption107436475
or    O
lead    O
poisoning    O

Mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475

Gold    O
-    O
mining    O
(    O
potential    O
Mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475
)    O

Suffering    O
from    O
mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475
,    O
Dong’en    O
waits    O
in    O
agony    O
for    O
an    O
opportunity    O
to    O
retaliate    O
.    O

During    O
her    O
marriage    O
,    O
Ann    O
accused    O
her    O
husband    O
of    O
attempting    O
to    O
poison    B-VolcanicEruption107436475
her    I-VolcanicEruption107436475
with    I-VolcanicEruption107436475
mercury    I-VolcanicEruption107436475
.    O

Mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475

Most    O
CFLs    O
contain    O
3–5    O
mg    O
per    O
bulb    O
,    O
with    O
the    O
bulbs    O
labeled    O
"    O
eco    O
-    O
friendly    O
"    O
containing    O
as    O
little    O
as    O
1    O
mg    O
.    O
Because    O
mercury    B-VolcanicEruption107436475
is    I-VolcanicEruption107436475
poisonous    I-VolcanicEruption107436475
,    O
even    O
these    O
small    O
amounts    O
are    O
a    O
concern    O
for    O
landfills    O
and    O
waste    O
incinerators    O
where    O
the    O
mercury    O
from    O
lamps    O
may    O
be    O
released    O
and    O
contribute    O
to    O
air    O
and    O
water    O
pollution    O
.    O

He    O
began    O
his    O
career    O
conducting    O
field    O
work    O
into    O
mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475
and    O
Minamata    O
disease    O
after    O
seeing    O
a    O
woman    O
with    O
the    O
disease    O
on    O
TV    O
in    O
1972    O
.    O

Mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475

Inside    O
the    O
cowboy    O
hat    O
is    O
a    O
memorial    O
bow    O
to    O
past    O
hatters    O
,    O
who    O
developed    O
brain    O
damage    O
from    O
treating    O
felt    O
with    O
toxic    B-VolcanicEruption107436475
mercury    I-VolcanicEruption107436475
(    O
which    O
gave    O
rise    O
to    O
the    O
expression    O
"    O
Mad    O
as    O
a    O
hatter    O
"    O
)    O
.    O

Some    O
experts    O
suggest    O
only    O
six    O
ounces    O
per    O
month    O
so    O
levels    O
of    O
mercury    O
in    O
the    O
body    O
do    O
not    O
reach    O
dangerous    B-VolcanicEruption107436475
level    I-VolcanicEruption107436475
.    O

The    O
"    O
Baoppuzi    O
"    O
lists    O
a    O
total    O
of    O
56    O
chemical    O
preparations    O
and    O
elixirs    O
,    O
8    O
of    O
which    O
were    O
poisonous    O
,    O
with    O
hallucinations    O
from    O
mercury    B-VolcanicEruption107436475
poisoning    I-VolcanicEruption107436475
the    O
most    O
commonly    O
reported    O
symptom    O
(    O
Needham    O
et    O
al    O
.    O


